Quest Diagnostics Inc/ US74834L1008 /
| 2024-05-31 8:30:24 PM | Chg. +0.90 | Volume | Bid8:30:36 PM | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 140.26USD | +0.65% | 31,551 Turnover: 4.42 mill. |
132.80Bid Size: 106 | -Ask Size: - | 22.65 bill.USD | 2.03% | 18.42 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 7.59 USD | -6.30% |
| EPS Diluted: | 7.49 USD | -6.02% |
| Revenues per Share: | 57.11 USD | -35.67% |
| Book Value per Share: | 39.15 USD | -26.51% |
| Cash Flow per Share: | 7.85 USD | -49.12% |
| Dividend per Share: | 2.84 USD | 7.58% |
| Total | in mill. | |
| Revenues: | 9,252.00 USD | -6.38% |
| Net Income: | 854.00 USD | -9.73% |
| Operating Cash Flow: | 1,272.00 USD | - |
| Cash and Cash Equivalents: | 686.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 18.42 | 18.17 |
| P/S Ratio: | 2.45 | 2.41 |
| P/BV ratio: | 3.57 | 3.52 |
| P/CF Ratio: | 17.80 | 17.56 |
| PEG: | -2.93 | -2.89 |
| Earnings Yield: | 5.43% | 5.50% |
| Dividend Yield: | 2.03% | 2.06% |
| Market Capitalization | ||
| Market Capitalization: | 22.65 bill. USD | 22.34 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 162 mill. | |
Profitability
| Gross Profit Margin: | 33.00% |
| EBIT Margin: | 13.64% |
| Net Profit Margin: | 9.23% |
| Return on Equity: | 13.47% |
| Return on Assets: | 6.09% |
Financial Strength
| Liquidity I / Cash Ratio: | 37.80% |
| Liquidity II / Quick Ratio: | 104.46% |
| Liquidity III / Current Ratio: | 130.69% |
| Debt / Equity Ratio: | 121.10% |
| Dynam. Debt / Equity Ratio: | 603.77% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
